0001820326-24-000002.txt : 20241203 0001820326-24-000002.hdr.sgml : 20241203 20241203111624 ACCESSION NUMBER: 0001820326-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241203 DATE AS OF CHANGE: 20241203 EFFECTIVENESS DATE: 20241203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manifold Biotechnologies, Inc. CENTRAL INDEX KEY: 0001820326 ORGANIZATION NAME: IRS NUMBER: 834588751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530923 FILM NUMBER: 241521690 BUSINESS ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 902 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: (801) 244-4494 MAIL ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 902 CITY: BOSTON STATE: MA ZIP: 02215 D 1 primary_doc.xml X0708 D LIVE 0001820326 Manifold Biotechnologies, Inc. 201 BROOKLINE AVENUE SUITE 902 BOSTON MA MASSACHUSETTS 02215 (801) 244-4494 DELAWARE None None Corporation true Gleb Kuznetsov 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Executive Officer Director Pierce Ogden 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Executive Officer Director Jory Bell 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Director Jeff Huber 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Director Steven Holtzman 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Director Steven J. Kafka 201 Brookline Avenue Suite 902 Boston MA MASSACHUSETTS 02215 Director Biotechnology Decline to Disclose 06b false 2024-11-18 false true true true false 0 32784801 32784801 0 The Total Offering Amount and Total Amount Sold include the aggregate exercise price of certain warrants to purchase shares of capital stock of the Issuer. false 10 0 0 0 false Manifold Biotechnologies, Inc. Gleb Kuznetsov Gleb Kuznetsov Chief Executive Officer 2024-11-26